Quick navigation menu :

Go to content
Go to the main sections menu
Go to the search engine
Go to the languages menu
Go to the help menu

You are here:

Home

visuel institutionnel la femme et l'enfant

main sections menu :

Help menu :

Stock information

Euronext Paris (SAN)

Quote: €47.46 . Level change: +2.21%
Last update: May 16, 2008
05.40 PM (CET)

NYSE (SNY)

Quote: $36.99 . Level change: -0.32%
Last update: May 16, 2008
04.13 PM (EST)

News

May 15, 2008 Multaq® (dronedarone) - Results of the ATHENA Clinical Trial

Audio webcast on May 15, at 9 p.m (CET)
Speakers: Marc Cluzel, Pierre Chancel and Jean-Pierre Lehner

To find out more on Multaq® (dronedarone) - Results of the ATHENA Clinical Trial

Sustainable Development

Go to the website

Press releases

May 15, 2008 Landmark ATHENA Study Findings With Multaq® (dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation

Download the press release dated May 15, 2008 (3)

May 15, 2008 District Court Decision affirmed in U.S. Lovenox® (enoxaparin sodium) patent infringement case

Download the press release dated May 15, 2008 (2)

May 15, 2008 Sanofi-aventis Annual General Meeting

Download the press release dated May 15, 2008 (1)

Focus on the Group

General Meeting 2008

Video webcast on May 14 at 3 p.m. (CET)
Speakers: Jean-François Dehecq, Gérard Le Fur and Jean-Claude Leroy

To find out more about the General Meeting 2008

Annual Review 2007

Download the Annual Review 2007

First Quarter 2008 Sales and Results

Audio webcast on April 30 at 8 a.m (CET)
Speakers: Hanspeter Spek, Jean-Claude Leroy and Marc Cluzel

To find out more on First Quarter 2008 Sales and Results

20-F 2007 sanofi-aventis

Download 20-F 2007

Reference document 2007 sanofi-aventis (in French)

Download the reference document of 2007

This website complies to the WCAG 1.0 Double-A international accessibility guidelines (details)

© sanofi-aventis 2004-2008 | Legal notice | Update: May 15, 2008